Free Trial

Regulus Therapeutics (RGLS) News Today

Regulus Therapeutics logo
$8.16 0.00 (0.00%)
As of 06/25/2025

RGLS Latest News

Novartis completes acquisition of Regulus Therapeutics
Regulus Therapeutics Inc.
Get Regulus Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RGLS and its competitors with MarketBeat's FREE daily newsletter.

RGLS Media Mentions By Week

RGLS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RGLS
News Sentiment

0.21

0.90

Average
Medical
News Sentiment

RGLS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RGLS Articles
This Week

3

3

RGLS Articles
Average Week

Get Regulus Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RGLS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:RGLS) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners